Norcantharidin-loaded liposomes potentiate radiotherapy by reprogramming tumor vasculature toward normalization
Biochemical and Biophysical Research Communications · 2025
DOI: 10.1016/j.bbrc.2025.152129 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2025. Verfasst von Jingming Luo und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China; Hangzhou Red Cross Hospital (Zhejiang Hospital of …. Hauptthemen laut MEDLINE: Bridged Bicyclo Compounds, Heterocyclic, Liposomes, Neovascularization, Pathologic, Angiogenesis Inhibitors. Die Arbeit nennt 70 Literaturangaben. Gefördert von: Zhejiang Medical Doctors Association, Zhejiang Chinese Medical University, Zhejiang Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Anti-angiogenic drugs are theorized to suppress tumor growth by blocking neovascularization. Notably, low-dose regimens may transiently normalize tumor vasculature. However, their rapid systemic clearance limits sustained vascular modulation. This study developed norcantharidin-loaded liposomes (NCTD-LPs) to prolong tumor vascular normalization in 4T1 tumor-bearing BALB/c mice, thereby alleviating hypoxia and enhancing radiotherapy efficacy. NCTD-LPs were synthesized via thin-film dispersion and characterized for particle size (140.94 ± 13.23 nm), zeta potential (29.54 ± 2.60 mV), drug-loading capacity (41.81 ± 5.75 %), and encapsulation efficiency (15.89 % ± 1.28 %). In the BALB/c model, dynamic changes in vascular markers (CD31, α-SMA) and hypoxia marker (HIF-1α) were quantified to identify the optimal vascular normalization window. Radiotherapy was administered during this window and compared with conventional regimens to evaluate therapeutic synergy. The coordinated changes in CD31, α-SMA and HIF-1α identified day 10 post-treatment as the optimal period for vascular normalization. The combined NCTD-LPs + radiation group achieved a tumor inhibition rate of 43.60 %, significantly surpassing radiation group (18.13 %) or NCTD-LPs group (17.24 %). Mechanistically, NCTD-LPs stabilized tumor neovasculature, curbed aberrant angiogenesis, and mitigated vascular leakage, collectively improving oxygen perfusion and radiation sensitivity. This study pioneers a liposome-enabled vascular normalization strategy to amplify radiotherapy outcomes, providing a translatable paradigm for combinatorial oncology therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China; Hangzhou Red Cross Hospital (Zhejiang Hospital of Integrated Traditional Chinese and Western Medicine), Hangzhou, Zhejia…
- School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
- Hangzhou Red Cross Hospital (Zhejiang Hospital of Integrated Traditional Chinese and Western Medicine), Hangzhou, Zhejiang, China.
- Zhejiang Cancer Hospital, The Key Laboratory of Zhejiang Province for Aptamers and Theranostics, Hangzhou, Zhejiang, China. Electronic address: wangzeng@zjcc.org.cn.
Förderung
- Zhejiang Medical Doctors Association
- Zhejiang Chinese Medical University
- Zhejiang Provincial Natural Science Foundation of China
- Chinese Medicine Science and Technology Plan of Zhejiang Province
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Luo, J., Shan, Y., Fan, X., Wu, C., Lin, L., Wang, Z., & Cai, X. (2025). Norcantharidin-loaded liposomes potentiate radiotherapy by reprogramming tumor vasculature toward normalization. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2025.152129
Vancouver
Luo J, Shan Y, Fan X, Wu C, Lin L, Wang Z, et al. Norcantharidin-loaded liposomes potentiate radiotherapy by reprogramming tumor vasculature toward normalization. Biochemical and Biophysical Research Communications. 2025. doi:10.1016/j.bbrc.2025.152129
BibTeX
@article{Luo2025,
author = {Luo, Jingming and Shan, Yanni and Fan, Xudong and Wu, Chongyang and Lin, Luting and Wang, Zeng and Cai, Xinjun},
title = {Norcantharidin-loaded liposomes potentiate radiotherapy by reprogramming tumor vasculature toward normalization},
journal = {Biochemical and Biophysical Research Communications},
year = {2025},
doi = {10.1016/j.bbrc.2025.152129}
}
EUVIMED